Get the Stockscreener App
0.6054
0.13%
-0.0008
After Hours:
.58
-0.0254
-4.20%
Scienture Holdings Inc stock is traded at $0.6054, with a volume of 709.69K.
It is down -0.13% in the last 24 hours and down -14.86% over the past month.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
See More
Previous Close:
$0.6062
Open:
$0.6114
24h Volume:
709.69K
Relative Volume:
0.03
Market Cap:
$24.60M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.75%
1M Performance:
-14.86%
6M Performance:
-45.70%
1Y Performance:
-92.26%
1-Day Range:
$0.581
$0.6266
1-Week Range:
$0.581
$0.75
52-Week Range:
$0.461
$8.19
Scienture Holdings Inc Stock (SCNX) Company Profile
Name
Scienture Holdings Inc
Sector
Industry
Phone
(800) 261 0281
Address
20 AUSTIN BLVD., COMMACK
Compare SCNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.6054 | 24.63M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.92 | 229.10M | 376.07M | -22.41M | 18.73M | -0.298 |
|
RDGT
Ridgetech Inc
|
4.04 | 71.50M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
PETS
Petmed Express Inc
|
2.94 | 63.68M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
WGRX
Wellgistics Health Inc
|
0.5725 | 63.39M | 28.99M | -39.20M | -3.34M | 0.00 |
|
POM
Pomdoctor Ltd Adr
|
0.4221 | 45.82M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc Stock (SCNX) Latest News
Scienture, BlinkRx announce strategic collaboration to expand access to Arbli - Yahoo Finance
Why Is Scienture Stock Gaining Today? - Benzinga
Scienture and BlinkRx partner to expand access to liquid losartan By Investing.com - Investing.com Australia
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium - marketscreener.com
Scienture (NASDAQ: SCNX) taps BlinkRx to launch Arbli, first ready-to-use losartan oral suspension in Q1 2026 - Stock Titan
A significant driver of top-line growth: Scienture Holdings Inc (SCNX) - Setenews
Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
MSN Money - MSN
Scienture Holdings, Inc. Cash Flow – HAM:4E4 - TradingView
Can Scienture Holdings Inc. (4E4) stock beat analyst consensusTrade Signal Summary & Consistent Return Strategy Ideas - Newser
Head to Head Analysis: Summit Therapeutics (NASDAQ:SMMT) and Scienture (NASDAQ:SCNX) - Defense World
Book value per share of Scienture Holdings, Inc. – HAM:4E4 - TradingView
Price to cash flow ratio of Scienture Holdings, Inc. – HAM:4E4 - TradingView
Price to book ratio of Scienture Holdings, Inc. – HAM:4E4 - TradingView
Cash per share of Scienture Holdings, Inc. – HAM:4E4 - TradingView
Scienture Holdings, Inc. Statistics – HAM:4E4 - TradingView
How Scienture Holdings Inc. stock performs in weak economyJuly 2025 Decliners & Stepwise Swing Trade Plans - Newser
Is Scienture Holdings Inc. (4E4) stock undervalued after correctionJuly 2025 Sector Moves & Verified Stock Trade Ideas - Newser
How geopolitical tensions affect Scienture Holdings Inc. stockQuarterly Portfolio Summary & Expert Curated Trade Setup Alerts - Newser
Is Scienture Holdings Inc. (4E4) stock a top pick for value investorsBull Run & Verified Trade Idea Suggestions - Newser
Will Scienture Holdings Inc. (4E4) stock deliver compounding returnsFed Meeting & Safe Capital Investment Plans - Newser
Is Scienture Holdings Inc. stock overvalued by current metricsWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - Newser
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025 - The Globe and Mail
Perhaps timely catching Scienture Holdings Inc (SCNX) would be a good idea - Setenews
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9-10, 2025 - The Manila Times
Is Scienture Holdings Inc. (4E4) stock considered safe havenPortfolio Return Report & Stock Portfolio Risk Management - Newser
Why ETFs are accumulating Scienture Holdings Inc. (4E4) stockTrade Entry Report & Reliable Price Breakout Signals - Newser
Will Scienture Holdings Inc. stock gain from government policiesWeekly Gains Report & Verified Momentum Stock Alerts - Newser
Will Scienture Holdings Inc. (4E4) stock outperform energy sector in 2025Profit Target & Trade Opportunity Analysis - Newser
Scienture Holdings (SCNX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Scienture Holdings Inc (SCNX) - MSN
Check out these key findings about Scienture Holdings Inc (SCNX) - Setenews
Is Scienture Holdings Inc. stock a buy for dividend growth2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Will Scienture Holdings Inc. (4E4) stock outperform benchmarksJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
Can Scienture Holdings Inc. stock weather global recessionWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
Is Scienture Holdings Inc. stock recession proofJuly 2025 Review & High Conviction Investment Ideas - newser.com
Will Scienture Holdings Inc. (4E4) stock outperform global peersTrade Entry Report & Weekly Stock Breakout Alerts - newser.com
Scienture Holdings Inc Stock (SCNX) Financials Data
There is no financial data for Scienture Holdings Inc (SCNX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
6.11%
9.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):